These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29691672)

  • 21. Revealing the Immunogenic Risk of Polymers.
    Li B; Yuan Z; Hung HC; Ma J; Jain P; Tsao C; Xie J; Zhang P; Lin X; Wu K; Jiang S
    Angew Chem Int Ed Engl; 2018 Oct; 57(42):13873-13876. PubMed ID: 30156051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using anti-poly(ethylene glycol) bioparticles for the quantitation of PEGylated nanoparticles.
    Hsieh YC; Cheng TC; Wang HE; Li JJ; Lin WW; Huang CC; Chuang CH; Wang YT; Wang JY; Roffler SR; Chuang KH; Cheng TL
    Sci Rep; 2016 Dec; 6():39119. PubMed ID: 27991598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of a Plug-and-Play Immunogenicity Assay in Cynomolgus Monkey Serum for ADCs at Early Stages of Drug Development.
    Carrasco-Triguero M; Davis H; Zhu Y; Coleman D; Nazzal D; Vu P; Kaur S
    J Immunol Res; 2016; 2016():2618575. PubMed ID: 27092313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primates.
    Yang Z; Wang J; Lu Q; Xu J; Kobayashi Y; Takakura T; Takimoto A; Yoshioka T; Lian C; Chen C; Zhang D; Zhang Y; Li S; Sun X; Tan Y; Yagi S; Frenkel EP; Hoffman RM
    Cancer Res; 2004 Sep; 64(18):6673-8. PubMed ID: 15374983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative determination of pegylated consensus interferon in rhesus monkey serum using a competitive enzyme-linked immunosorbent assay.
    Cao J; Du Y; Tian H; Gao XD; Yao WB
    Immunopharmacol Immunotoxicol; 2009; 31(4):543-9. PubMed ID: 19874220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of a novel immunogenicity assay to detect anti-drug and anti-PEG antibodies simultaneously with high sensitivity.
    Bivi N; Swearingen CA; Shockley TE; Sloan JH; Pottanat TG; Carter QL; Hodsdon ME; Siegel RW; Konrad RJ
    J Immunol Methods; 2020 Nov; 486():112856. PubMed ID: 32916164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo efficacy of recombinant methioninase is enhanced by the combination of polyethylene glycol conjugation and pyridoxal 5'-phosphate supplementation.
    Sun X; Yang Z; Li S; Tan Y; Zhang N; Wang X; Yagi S; Yoshioka T; Takimoto A; Mitsushima K; Suginaka A; Frenkel EP; Hoffman RM
    Cancer Res; 2003 Dec; 63(23):8377-83. PubMed ID: 14678999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies nonresponders to pegylated interferon-ribavirin combination therapy after 4 weeks of treatment.
    Orlent H; Desombere I; Hansen B; Van Vlierberghe H; Haagmans B; De Knegt RJ; Schalm SW; Leroux-Roels G; Janssen HL;
    Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1443-8. PubMed ID: 21389795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement Effect of a Variable Topology of a Membrane-Tethered Anti-Poly(ethylene glycol) Antibody on the Sensitivity for Quantifying PEG and PEGylated Molecules.
    Lin WW; Cheng YA; Kao CH; Roffler SR; Lee YC; Chen BM; Hsieh YC; Chen IJ; Huang BC; Wang YT; Tung YC; Huang MY; Chen FM; Cheng TL
    Anal Chem; 2017 Jun; 89(11):6082-6090. PubMed ID: 28485140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of native or pegylated E. coli and Erwinia asparaginases assessed by ELISA and surface plasmon resonance (SPR-biacore) assays of IgG antibodies (Ab) in sera from patients with acute lymphoblastic leukemia (ALL).
    Avramis VI; Avramis EV; Hunter W; Long MC
    Anticancer Res; 2009 Jan; 29(1):299-302. PubMed ID: 19331165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of poly(ethylene glycol) by cell-based anti-poly(ethylene glycol) ELISA.
    Chuang KH; Tzou SC; Cheng TC; Kao CH; Tseng WL; Shiea J; Liao KW; Wang YM; Chang YC; Huang BJ; Wu CJ; Chu PY; Roffler SR; Cheng TL
    Anal Chem; 2010 Mar; 82(6):2355-62. PubMed ID: 20178318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of drug tolerance in immunogenicity testing by acid treatment on Biacore.
    Sickert D; Kroeger K; Zickler C; Chokote E; Winkler B; Grenet JM; Legay F; Zaar A
    J Immunol Methods; 2008 May; 334(1-2):29-36. PubMed ID: 18304570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development, validation, and application of ELISA for detection of anti-HD105 antibodies in pre-clinical safety evaluation using monkeys.
    Choi WH; Jo HR; Jeon EJ; Youm SY; Jeon JS; Son YG; You WK; Koh WS; Lee SH; Kim SK
    J Pharm Biomed Anal; 2016 Nov; 131():309-315. PubMed ID: 27619177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-PEG IgM production via a PEGylated nano-carrier system for nucleic acid delivery.
    Ichihara M; Moriyoshi N; Lila AS; Ishida T; Kiwada H
    Methods Mol Biol; 2013; 948():35-47. PubMed ID: 23070762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serum.
    Wang SL; Ohrmund L; Hauenstein S; Salbato J; Reddy R; Monk P; Lockton S; Ling N; Singh S
    J Immunol Methods; 2012 Aug; 382(1-2):177-88. PubMed ID: 22691619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging Technologies and Generic Assays for the Detection of Anti-Drug Antibodies.
    Partridge MA; Purushothama S; Elango C; Lu Y
    J Immunol Res; 2016; 2016():6262383. PubMed ID: 27556048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of an Anti-poly(ethylene glycol) (anti-PEG) Cell-Based Capture System To Quantify PEG and PEGylated Molecules.
    Lin WW; Hsieh YC; Cheng YA; Chuang KH; Huang CC; Chuang CH; Chen IJ; Cheng KW; Lu YC; Cheng TC; Wang YT; Roffler SR; Cheng TL
    Anal Chem; 2016 Dec; 88(24):12371-12379. PubMed ID: 28193011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the NIDS® rapid assay with ELISA methods in immunogenicity testing of two biotherapeutics.
    Pan J; Small T; Qin D; Li S; Wang L; Chen D; Pauley C; Verch T; Kaplanski C; Bakhtiar R; Vallejo YR; Yin R
    J Pharmacol Toxicol Methods; 2011; 63(2):150-9. PubMed ID: 20868758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery in polyethylene glycol immunogenicity: The characteristic of intergenerational inheritance of anti-polyethylene glycol IgG.
    Gao X; Yan X; Wang R; Li C; Qiu Q; Liu M; Tang X; Yan N; Li J; Song Y; Deng Y
    Eur J Pharm Biopharm; 2022 Mar; 172():89-100. PubMed ID: 35134513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of anti-PEG antibodies on PEGylated nanoparticles fate in vivo.
    Park K
    J Control Release; 2018 Oct; 287():257. PubMed ID: 30243349
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.